Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Katanin regulatory subunit B1 like 1 pseudogene 6 (KATNBL1P6) is a classified pseudogene in the human genome, with no evidence of protein-coding potential or therapeutic target activity[1][3][7]. Pseudogenes are DNA sequences resembling functional genes but typically lack the ability to code for functional proteins, often due to loss-of-function mutations, frameshifts, or premature stop codons[5]. Some pseudogenes can be transcribed and may play a regulatory role at the RNA level, such as serving as decoys for microRNAs or modulating the expression of their parental genes[4][8]. However, there is no direct functional or biological information specifically linking KATNBL1P6 to such regulatory roles, disease, or molecular pathology. In summary, KATNBL1P6 is not a therapeutic target, does not encode a functional protein, and has no established disease associations, interacting drugs, or molecular functions beyond being annotated as a pseudogene.
Not applicable (as there are no known drugs that target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Katanin regulatory subunit B1 like 1 pseudogene 6 (KATNBL1P6).